Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005393663> ?p ?o ?g. }
- W2005393663 endingPage "126" @default.
- W2005393663 startingPage "119" @default.
- W2005393663 abstract "1. The pharmacological properties of RS 23597-190 (3-(piperdine-1-yl)-propyl-4-amino-5-chloro-2-methoxy benzoate hydrochloride) have been studied in vitro and in vivo. 2. RS 23597-190 competitively antagonized 5-HT4 receptor-mediated relaxations of rat, carbachol precontracted oesophageal muscularis mucosae, (pA2 = 7.8 +/- 0.1; Schild slope = 1.2 +/- 0.2). Affinity estimates (-log KB) at 5-HT4 receptors using either renzapride or SC-53116 as agonists yielded a -log KB value of 8.0 +/- 0.01. In contrast, RS 23597-190 failed to antagonize contractile responses to 5-HT of guinea-pig ileal 5-HT3 receptors, even at concentrations up to 10 microM. 3. Increases in short-circuit current, induced by 5-HT, were studied in guinea-pig ileal mucosal sheets. Concentration-response curves to 5-HT were biphasic, with the high potency phase to 5-HT inhibited by RS 23597-190 and mimicked by 5-methoxytryptamine. The -log KB value for RS 23597-190 at the high potency phase was 7.3 confirming that 5-HT4 receptors mediated the high potency phase. 4. In rat isolated vagus nerve, 5-HT elicited a slow, maintained depolarization at low concentrations and a rapid, transient depolarization at higher concentrations. The high potency, slow depolarizing phase to 5-HT was abolished selectively in the presence of 1 microM RS 23597-190 and the low potency phase was abolished selectively in the presence of 1 microM ondansetron. These data confirm that 5-HT4 and 5-HT3 receptors mediated slow and fast depolarization responses, respectively. 5. At 5-HT3 binding sites in membranes from NG 108-15 cells, labelled by [3H]-quipazine, RS 23597-190 exhibited an apparent affinity (- log Ki) of 5.7 +/- 0.1. At 5-HT3 receptors in membranes from rat cerebral cortex, labelled by [3H]-RS 42358-197, the apparent affinity (- log Ki) of RS 23597-190 was also 5.7 +/- 0.1. In both studies, Hill coefficients were not significantly different from unity. At 5-HT1A, 5-HT2,muscarinic M1, M2, M3, M4 and dopamine D1 and D2 receptors, RS 23597-190 exhibited low apparent affinities, with all - log Ki values less than 5.5.6. Intravenous infusion of RS 23597-190 in the conscious, restrained rat antagonized the von Bezold Jarisch reflex induced by 2-methyl 5-HT, with an ID50 of 300 microg kg-1 min-1, i.v. In the anaesthetized,bilaterally vagotomized micropig, RS 23597-190 (6 mg kg-1, i.v.) antagonized 5-HT-induced tachycardia with a half-life of 77 (63-99) min. Transient arrhythmic effects were noted after administration of the compound.7. In conclusion, RS 23597-190 acts as a high affinity, selective competitive antagonist at 5-HT4 receptors. Thus, the compound appears to be a useful tool for 5-HT4 receptor identification in vitro. In vivo, the compound is rapidly metabolized in pigs such that 5-HT4 blockade is not maintained. However,in the rat, when given by infusion, RS 23597-190 antagonizes 5-HT3 mediated responses, at doses consistent with a low affinity 5-HT3 receptor. These data suggest that, under appropriate experimental conditions, RS 23597-190 may also be used in vivo to characterize further 5-HT4 receptor function." @default.
- W2005393663 created "2016-06-24" @default.
- W2005393663 creator A5010050040 @default.
- W2005393663 creator A5014165482 @default.
- W2005393663 creator A5026950758 @default.
- W2005393663 creator A5037782599 @default.
- W2005393663 creator A5052230481 @default.
- W2005393663 creator A5068994903 @default.
- W2005393663 creator A5070529034 @default.
- W2005393663 creator A5072070682 @default.
- W2005393663 date "1993-09-01" @default.
- W2005393663 modified "2023-10-17" @default.
- W2005393663 title "RS 23597-190: a potent and selective 5-HT4 receptor antagonist" @default.
- W2005393663 cites W1829862232 @default.
- W2005393663 cites W1963575053 @default.
- W2005393663 cites W1973268900 @default.
- W2005393663 cites W1975661708 @default.
- W2005393663 cites W1980368200 @default.
- W2005393663 cites W1981401938 @default.
- W2005393663 cites W1994441102 @default.
- W2005393663 cites W1995604771 @default.
- W2005393663 cites W2001676058 @default.
- W2005393663 cites W2006686605 @default.
- W2005393663 cites W2010795900 @default.
- W2005393663 cites W2016478987 @default.
- W2005393663 cites W2032554664 @default.
- W2005393663 cites W2035977493 @default.
- W2005393663 cites W2038945391 @default.
- W2005393663 cites W2041416021 @default.
- W2005393663 cites W2042669909 @default.
- W2005393663 cites W2043813981 @default.
- W2005393663 cites W2044861397 @default.
- W2005393663 cites W2053074524 @default.
- W2005393663 cites W2057971042 @default.
- W2005393663 cites W2065898488 @default.
- W2005393663 cites W2072458796 @default.
- W2005393663 cites W2077379054 @default.
- W2005393663 cites W2078954088 @default.
- W2005393663 cites W2081162866 @default.
- W2005393663 cites W2085238973 @default.
- W2005393663 cites W2097727344 @default.
- W2005393663 cites W2129488948 @default.
- W2005393663 cites W2159292998 @default.
- W2005393663 cites W2268997758 @default.
- W2005393663 cites W2322667884 @default.
- W2005393663 cites W2596280533 @default.
- W2005393663 doi "https://doi.org/10.1111/j.1476-5381.1993.tb13780.x" @default.
- W2005393663 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2176024" @default.
- W2005393663 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8220871" @default.
- W2005393663 hasPublicationYear "1993" @default.
- W2005393663 type Work @default.
- W2005393663 sameAs 2005393663 @default.
- W2005393663 citedByCount "53" @default.
- W2005393663 countsByYear W20053936632013 @default.
- W2005393663 countsByYear W20053936632014 @default.
- W2005393663 countsByYear W20053936632015 @default.
- W2005393663 countsByYear W20053936632016 @default.
- W2005393663 countsByYear W20053936632017 @default.
- W2005393663 countsByYear W20053936632018 @default.
- W2005393663 countsByYear W20053936632021 @default.
- W2005393663 crossrefType "journal-article" @default.
- W2005393663 hasAuthorship W2005393663A5010050040 @default.
- W2005393663 hasAuthorship W2005393663A5014165482 @default.
- W2005393663 hasAuthorship W2005393663A5026950758 @default.
- W2005393663 hasAuthorship W2005393663A5037782599 @default.
- W2005393663 hasAuthorship W2005393663A5052230481 @default.
- W2005393663 hasAuthorship W2005393663A5068994903 @default.
- W2005393663 hasAuthorship W2005393663A5070529034 @default.
- W2005393663 hasAuthorship W2005393663A5072070682 @default.
- W2005393663 hasBestOaLocation W20053936631 @default.
- W2005393663 hasConcept C126322002 @default.
- W2005393663 hasConcept C134018914 @default.
- W2005393663 hasConcept C170493617 @default.
- W2005393663 hasConcept C185592680 @default.
- W2005393663 hasConcept C192096249 @default.
- W2005393663 hasConcept C202751555 @default.
- W2005393663 hasConcept C2775864247 @default.
- W2005393663 hasConcept C2776885963 @default.
- W2005393663 hasConcept C2778122271 @default.
- W2005393663 hasConcept C2778938600 @default.
- W2005393663 hasConcept C2778988552 @default.
- W2005393663 hasConcept C38533456 @default.
- W2005393663 hasConcept C4141045 @default.
- W2005393663 hasConcept C53910766 @default.
- W2005393663 hasConcept C55493867 @default.
- W2005393663 hasConcept C57992300 @default.
- W2005393663 hasConcept C71924100 @default.
- W2005393663 hasConcept C86803240 @default.
- W2005393663 hasConcept C98274493 @default.
- W2005393663 hasConceptScore W2005393663C126322002 @default.
- W2005393663 hasConceptScore W2005393663C134018914 @default.
- W2005393663 hasConceptScore W2005393663C170493617 @default.
- W2005393663 hasConceptScore W2005393663C185592680 @default.
- W2005393663 hasConceptScore W2005393663C192096249 @default.
- W2005393663 hasConceptScore W2005393663C202751555 @default.
- W2005393663 hasConceptScore W2005393663C2775864247 @default.
- W2005393663 hasConceptScore W2005393663C2776885963 @default.
- W2005393663 hasConceptScore W2005393663C2778122271 @default.